Who is this course for?
Care providers and facilitator trainees seeking training in psychedelic facilitation and psychedelic-assisted therapy support.
EMBARK Open Access is a comprehensive course designed to equip care providers with the skills and knowledge to provide ethical, culturally competent, and trauma-informed psychedelic facilitation.
Cybin
English
25 years
EMBARK Open Access (OA) is a comprehensive course designed to equip care providers with the skills and knowledge to provide ethical, culturally competent, and trauma-informed psychedelic facilitation. Based on the innovative EMBARK model, which combines elements from over a dozen previous approaches, this course focuses on six clinical domains and four care cornerstones that ensure effective therapeutic support within a broader framework of collective caregiving.
The EMBARK Training Program offers a blended model of live and self-guided activities, preparing participants to become Certified EMBARK Facilitators. The curriculum includes didactics, experiential activities, group discussions, independent study, and clinical supervision, led by a team of 28 faculty members, supervisors, and advisors. EMBARK's creators, Bill Brennan, PhD, and Alex Belser, PhD, have developed the program based on process evidence in psychedelic clinical practice and the experiences of senior teachers and supervisors.
The EMBARK model has been published in the peer-reviewed journal Frontiers in Psychology and can be adapted to different clinical indications and problems, such as depression, alcohol use disorder, and anxiety. With its transdiagnostic treatment model and commitment to accessibility, EMBARK Open Access aims to revolutionize mental healthcare by providing innovative psychedelic-based treatment options.
Care providers and facilitator trainees seeking training in psychedelic facilitation and psychedelic-assisted therapy support.
Cybin Inc. (founded 2019) is a Canadian clinical-stage biopharmaceutical company developing psychedelic-based therapeutics—now operating as Helus Pharma—focused on proprietary novel serotonergic agonists and deuterated psilocin analogs for mental health conditions.
Care providers and facilitator trainees seeking training in psychedelic facilitation and psychedelic-assisted therapy support.
Format: Hybrid. Time commitment: 25 years.
The listed price is $0. Confirm the latest tuition, fees, and payment options with [object Object].
Accreditation note: The model has been published in Frontiers in Psychology.. Confirm credential eligibility directly with the provider before enrolling.
The current listing status is No New Dates. Use the provider website for the latest enrollment status.
By Psychedelics Today
Shares course skills and categories
Navigating Psychedelics for Clinicians and Therapists is a comprehensive course designed specifically for mental health professionals to educate them on psychedelics and psychedelic integration.
Source lists: Estimated 13.5 hours
Delivery: Online + Self-paced
No medicine self-experience listed
By SoundMind
Shares course skills and categories
SoundMind Psychedelic Facilitator Training is an 8-month certificate program for Oregon psilocybin facilitator training. It covers psychedelic-assisted therapy topics, including ketamine, psilocybin, and MDMA in therapeutic settings.
Next cohort: Sep 1, 2026
Delivery: Online + United States
Includes medicine self-experience
By IPI
Shares course skills and categories
The IPI Online Psychedelic-Assisted Therapy Training is a year-long program designed for therapists, physicians, nurses, and other allied mental healthcare professionals who want to expand their skill set in psychedelic-assisted therapy.
Source lists: 140 hours
Delivery: Online